This information was published on 2025-10-16T07:04:04 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2593260 (IR 1879674) |
| (220) |
05 Sep 2025
|
| (300) |
GB, 28 Mar 2025, UK00004180938
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines. |
| (540) | QAMZEBRY |
| (550) | Word |
| (730) |
Glaxo Group Limited
|
Find out more about publications on the About page.